Advertisement

Topics

C. R. Bard, Inc. Company Profile

10:35 EDT 21st June 2018 | BioPortfolio

Cost of goods sold


News Articles [21 Associated News Articles listed on BioPortfolio]

$24B deal to buy C.R. Bard finalized by Becton Dickinson

The $24 billion acquisition of C.R. Bard has been completed by Becton Dickinson, making Bard its wholly owned subsidiary.  -More- 

BD Statement On MOFCOM Clearance Of Bard Acquisition

"MOFCOM clearance was the final regulatory approval needed to complete the Bard acquisition," said Vincent A. Forlenza, chairman and CEO of BD. "We look Read more...

China OKs Becton Dickinson's $24B C. R. Bard takeover

Becton Dickinson received approval from China's Ministry of Commerce for its proposed $24 billion acquisition of C. R. Bard.  -More- 

BD completes acquisition of medical technology firm Bard

Becton, Dickinson and Company (BD) has completed the acquisition of US medical technology firm C. R. Bard for about $24bn.

BD completes acquisition of medical technology firm C. R. Bard

Becton, Dickinson and Company (BD) has completed the acquisition of US medical technology firm C. R. Bard for about $24bn.

Jury Awards Plaintiff $68M In Bard Mesh Case

C.R. Bard has lost the first transvaginal mesh case to be tried in New Jersey, but there are another 150...    

C. R. Bard, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 19022018] Prices from USD $350

C. R. Bard, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's C. R. Bard, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report i...

Becton, Dickinson's Dividend Continues To Grow Post C.R. Bard Acquisition

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Cordran [Watson Pharma, Inc.]

Cordran® Tape Flurandrenolide Tape, USP For the Physician Rx only Revised: May 2010

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Microvascular Decompression of Facial Nerve and Pexy of the Left Vertebral Artery for Left Hemifacial Spasm: 3-Dimensional Operative Video.

A 73-yr-old man presented with intractable left hemifacial spasm of 4 yr duration. Brain magnetic resonance imaging showed significant compression of left facial nerve by the left vertebral artery (VA...

The Bursts and Lulls of Multimodal Interaction: Temporal Distributions of Behavior Reveal Differences Between Verbal and Non-Verbal Communication.

Recent studies of naturalistic face-to-face communication have demonstrated coordination patterns such as the temporal matching of verbal and non-verbal behavior, which provides evidence for the propo...

Clinical Trials [21 Associated Clinical Trials listed on BioPortfolio]

Study Of Hernia Repair Utilizing The Bard Ventrio Hernia Patch

This study will collect data on patients undergoing hernia repair using the Bard Ventrio Hernia Patch. The study will evaluate hernia recurrence rates, operating time, quality of life and...

Utility, Safety, and Effectiveness of the Bard LifeStent 5F Vascular Stent System

The medical device being examined in this study is the Bard® LifeStent® 5F Vascular Stent System. It is intended for use in patients who suffer from peripheral artery disease (PAD). PAD ...

A Single Arm Trial Evaluating the BARD Lutonix Drug-Coated Balloon (LTX DCB) for Treatment of Femoropopliteal Arteries

To assess the safety and efficacy of the BARD LTX DCB for treatment of stenosis or occlusion of the superficial femoral and popliteal arteries.

Safety and Efficacy of Midline and PICC

The purpose of this study is to assess the non-inferiority for safety and efficacy of using Midline in comparison with PICC for intravenous therapy that do not require a central catheter.

The Study to Compare the Cordis SMART™ Stent System With the Bard® Luminexx™ Stent

This study will look at the performance of the Cordis S.M.A.R.T.™ CONTROL ™ Nitinol Stent System for the treatment of TASC C & D superficial femoral artery long lesions (up to 22 cm) i...

Companies [13 Associated Companies listed on BioPortfolio]

CR Bard

C. R. Bard, Inc. is a leading multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the fields of Vascular, Urology, Oncology, and Surgical Specialt...

C. R. Bard, Inc

C. R. Bard, Inc. is a leading multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the fields of Vascular, Urology, Oncology, and Surgical Specialt...

BISNAR | CHASE

The BISNAR | CHASE Orange County, California Bard Avaulta Mesh Lawyers represent people who have been very seriously injured or lost a family member due to defective products such...

C.R. Bard, Inc.

Bard Peripheral Vascular OEM Products

More Information about "C. R. Bard, Inc." on BioPortfolio

We have published hundreds of C. R. Bard, Inc. news stories on BioPortfolio along with dozens of C. R. Bard, Inc. Clinical Trials and PubMed Articles about C. R. Bard, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of C. R. Bard, Inc. Companies in our database. You can also find out about relevant C. R. Bard, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record